Guest speaker: Sasha Shulgin

Ways to help the Shulgins

For non-tax-deductible contributions, Paypal $ to [annandsashashulgin@comcast.net] or snailmail:
Sasha Shulgin, c/o Transform Press, PO Box 13675, Berkeley CA 94712.

For tax-deductible online donations to support the completion of Shulgin publishing projects that are underway: http://www.erowid.org/donations/project_shulgin.php

Please spread this information.

Read the story
of a member of
our community
who needs your help

PROGRAM NOTES:

In his next to last talk at the legendary Entheobotany Conferences in Palenque, Mexico, Sasha Shulgin holds forth on a host of topics ranging from his experiences in the navy during World War II, to how he first developed an interest in psychedelic chemistry, and on to a description of the processes and protocols he uses to develop new psychoactive compounds. The talk was given in January 2001.

Download
MP3
PCs – Right click, select option
Macs – Ctrl-Click, select option

Guest speakers: Gary Fisher and Charlie Grob

PROGRAM NOTES:

In 1963, Dr. Gary Fisher wrote a paper titled

Interim report on Research project:
An Investigation to Determine Therapeutic Effectiveness of
LSD-25 and Psilocybin on Hospitalized
Severely Emotionally Disturbed Children
(This link will take you to the full report.)

Download
MP3
PCs – Right click, select option
Macs – Ctrl-Click, select option

» Continue reading “Podcast 156 – “Treating Childhood Schizophrenia with Psychedelics””

Guest speaker: Michael Mithoefer

PROGRAM NOTES:

(Minutes : Seconds into program)

06:19 Michael tells a little about how his study came about and its current status.

08:27 Michael describes the screening, preparation, and flow of the experience for qualified participants.

11:56 “We were able to go back, retroactively, and offer MDMA to everybody that had gotten [only] the placebo so far.”

14:06 “Everybody who’s gotten MDMA has had a significant improvement, either temporarily or sustained. More than half, the majority of people have had a very dramatic and sustained improvement.”

18:35 “This is a pilot study, and we’re not really looking to prove efficacy. We’re looking to prove we can work safely with these subjects, and it has at least has a strong trend toward being effective.”

22:48 A discussion about the neurotoxicity of MDMA.

23:12 “There is still a question about neurotixicity (or at least decreases in some neuro functions) with heavy recreational use. It looks like there probably is some effect, although that is still controversial. . . . It looks like [using MDMA] less than 50 times there is no effect. It is still not known if there is an effect higher than that.”

28:31 “The question is about how sustainable is the effect. It really looks like, for some people, two sessions is enough to really, significantly heal PTSD.”

Download
MP3
PCs – Right click, select option
Macs – Ctrl-Click, select option